UV Hydrophilic Coating

Biocoat, Inc.'s HYDAK® UV Hydrophilic Coating Awarded USPTO Patent Biocoat, Inc., a specialty manufacturer of hydrophilic biomaterial coatings, services, and dip-coating equipment for medical devices, announced today that the United States Patent and Trademark Office has granted a patent to its HYDAK® UV coating (USPTO). "Biocoat's HYDAK UV coating is built on a bi-laminar platform that offers industry-leading results in lubricity, durability and particulates, which are the main criteria for measuring hydrophilic coating performance," said Dr. Bob Hergenrother, Vice President of Research, Development, and Innovation at Biocoat. "The acceptance of our USPTO filing confirms that our unique and proprietary technology is unmatched in the marketplace." Biocoat is the only hydrophilic coating provider with industry-leading performance in both UV and Thermal Heat curing systems. UV cure coatings are used on a wide range of medical devices that require a hydrophilic coating, especially in the cardiovascular market. Thermal curing is frequently used on interventional medical devices that require exceptionally high performance. Furthermore, thermal curing can be used to coat the inner diameter of substrate materials or on delivery cartridges used to place intraocular lenses (IOLs). "Our HYDAK UV coating was introduced to the market in early 2020 and since then, we have had significant interest from both current and new customers," said Jim Moran, President and CEO of Biocoat. "The entire Biocoat team has worked tirelessly to support this new product launch, and we are proud to be recognized by this patent for our innovation. Our team is laser focused on ensuring that we offer customers the best hydrophilic coatings and product development support available in the industry today". Scott Cramer, Board Chair for Biocoat, added, "The Biocoat team continues to innovate, which has pushed the organization to be recognized as the leading full-service hydrophilic coating company in the medical device industry."       Note: Content may be edited for style and length.   Source